Abstract: Opioids given to pregnant and parturient women are relatively freely transferred across the placenta. Spinal, epidural and intravenous fentanyl has been studied in pregnant women and neonates, but foetal safety of fentanyl dosing with transdermal patch during pregnancy and labour is not sufficiently studied. Foetal pH is physiologically lower than maternal pH, and thus, opioids, which are weak bases, are ionized and may cumulate to foetus. Foetal asphyxia may further worsen acidosis, and ion trapping induced by low pH is assumed to increase the foetal exposure to opioids. Here, we show that no correlation between foetal acidosis and ion trapping of fentanyl could be found. In three experiments, 29 pregnant sheep were administered fentanyl with 2 lg/kg/h patch supplemented with IV boluses/infusion. Foetal exposure to fentanyl was extensive, median 0.34 ng/ml (quartiles 0.21, 0.42), yet drug accumulation to foetus was not observed, and median of foetal/maternal concentration (F/M) ratio was 0.63 (0.43, 0.75) during the first hours after the fentanyl administration. Low foetal pH and pH difference between ewe and the foetus did not correlate with fentanyl concentration in the foetus or F/M ratio. At steady-state during the second patch worn, foetal plasma fentanyl was low, 0.13 ng/ml, and the median of F/M ratio was 0.69. Our results demonstrate that drug accumulation to foetus caused by ion trapping seen with some weak base opioids may not be that significant with fentanyl. These results have a clinical relevance when fentanyl is dosed to pregnant woman and the foetus is acidemic.
Fentanyl, a synthetic opioid derivative, is widely used for analgesia during labour and in caesarean section and also in pregnant women having surgery or suffering from severe pain. Fentanyl has a rapid onset of action and is metabolized to inactive metabolites, which makes it a feasible drug for analgesia during labour and pregnancy. Spinal, epidural and intravenous (IV) fentanyl has been studied in pregnant women and neonates [1] . However, foetal and neonatal safety of fentanyl administration by other routes, such as transdermal or transmucosal [2] , during labour is not sufficiently studied.
During labour, uterine contractions cause a transient decrease in placental blood flow, which may affect gas exchange between mother and foetus. This can lead to foetal acidosis that is typically caused by both respiratory and metabolic components. Weak basic compounds accumulate to the foetus by ion trapping due to the decreased foetal pH [3] [4] [5] [6] . Because the pKa of fentanyl is 8.12 [7] , which is similar to the drugs studied previously [1] [2] [3] [4] , foetal acidosis could, in theory, increase placental transfer of fentanyl. This has a clinical relevance if fentanyl is administered to a woman during labour and the foetus is acidemic. However, the association between foetal acidosis and fentanyl accumulation to foetus has not been studied previously.
Our hypothesis was that physiological foetal acidosis that is worsened during asphyxia may increase foetal exposure to fentanyl administered to ewe. To evaluate the hypothesis, we designed the present experimental study, where the primary aim was to determine fentanyl exposure of the foetus after IV and transdermal administration to pregnant ewe. Secondary aim was to study ion trapping of fentanyl consequent upon pH difference between ewe and the foetus.
Materials and Methods
Animals. The study protocol was reviewed and approved by the National Animal Experiment Board of Finland (ESAVI/1007/04.10.07/ 2014, 13 March 2014). The animal care and experimental procedures were conducted according to the national legislation [8, 9] and the EU Directive 2010/63/EU [10] . Altogether, 29 time-mated 2-to 10-yearold Aland landrace ewes, weighing 42-67 kg (median 51 kg) at 118-127 gestational days (Lammastila Sikka Talu, University of Turku, Rym€ attyl€ a, Finland), were used.
Exposure study. The exposure study was conducted in three experiments (table 1) . Surgical procedures, laparotomy and hysterotomy to ewes and thoracotomy to foetus were carried out as described by Erkinaro et al. [11] . Transdermal and IV fentanyl doses were calculated based on ewe's weight. In all experiments, ewe's both external jugular veins were catheterized, and separate veins were used for fentanyl administration and blood sampling.
During exposure study, transdermal fentanyl matrix patches 25-100 lg (Durogesic; Janssen Pharmaceutica N. V., Beerse, Belgium) were used to obtain a total dose of 2.0 lg/kg/h (range: 1.87-2.13 lg/kg/h). The skin of patch application site was prepared and adhesive tape was used to hold the patches in place as described earlier [12] . Before surgery, a standardized endotracheal anaesthesia Author for correspondence: Merja Kokki, Anaesthesia and Operative Services, Kuopio University Hospital, PO Box 100, Kuopio, FI-70029 KYS, Finland (e-mail: merja.kokki@kuh.fi).
was induced with IV propofol and maintained with isoflurane end-tidal concentration of 1-2.5% in an oxygen/air mixture. All ewes received 1 g of ampicillin IV preoperatively and thereafter at every 24 hr.
In the first experiment, sheep received 2 lg/kg bolus of fentanyl IV (Fentanyl Hameln 50 lg/ml, Hameln pharmaceuticals GmbH, Hameln, Germany) in the beginning of surgery, followed by 1 lg/kg intraoperative maintenance doses at 1-hr intervals. At the end of surgery, 1 lg/kg intramuscular bolus of fentanyl was administered and a transdermal fentanyl matrix patch at a dose rate of 2 lg/kg/h was applied onto the skin under the tail and left in place for 72 hr to be replaced then by a new patch.
In the second experiment, sheep received 2 lg/kg IV bolus of fentanyl followed by 1 lg/kg intraoperative maintenance doses at 30-min. intervals. Transdermal fentanyl matrix patch was applied onto the skin of left antebrachium after anaesthesia induction just before surgery. At the end of surgery, 1 lg/kg intramuscular fentanyl was administered and fentanyl patch was left in place for 72 hr to be replaced by a new patch.
In the third experiment, transdermal fentanyl matrix patch was applied onto the skin of left antebrachium 1 hr before surgery to be worn for 72 hr and replaced then by a new patch. After anaesthesia induction, 2 lg/kg IV fentanyl bolus was administered followed by 2.5 lg/kg/h continuous IV infusion during surgery. Infusion was stopped 30 min. before the end of surgery.
Blood gas analysis and sample collection. Simultaneously drawn maternal and foetal arterial blood samples were analysed for blood gas values with i-STAT-1 (Abbott Point of Care Inc., Abbott Park, IL, USA) during surgery. Simultaneously with arterial samples, paired venous blood samples were obtained from ewes' external jugular vein and foetuses superior vena cava catheters for plasma fentanyl quantitation. After the blood samples were drawn, the catheters were flushed with 0.9% NaCl and 50 IU/ml heparin solution.
The first paired blood samples were collected for blood gases and fentanyl concentrations as soon as the foetuses had a carotid artery and superior vena cava catheters placed. After that, the blood samples were collected before each fentanyl bolus administration and at the end of surgery. The collection times were recorded for later analysis. In the second and third experiment, we obtained the paired blood samples from a total of eight ewes-foetus pairs, four pairs in both experiments, after 4 or 5 days of fentanyl patch worn, that is during the second fentanyl patch worn.
Blood samples were collected in heparinized plasma tubes, which were turned 10 times and then allowed to stand in room temperature for 30 min. The blood was centrifuged at 985 9 g for 10 min. Plasma samples were stored first at À35°C and within a week moved to À70°C until analysed.
Fentanyl quantitation. Plasma was analysed with ultra-performance liquid chromatography-mass spectrometry system (Waters Acquity UPLC liquid chromatograph; Waters corp, Milford, MA, USA) as described earlier [12] .
At the lower limit of quantification (0.004 ng/ml), the accuracy of assay was 127% and the coefficient of variation was 6.6%. The calibration range was 0.004-20 ng/ml. Data analysis. Pearson's product-moment correlations for pH difference between maternal and foetal plasma, absolute foetal plasma pH, F/M concentration ratio and absolute foetal fentanyl concentration in plasma were calculated. All data analyses were performed with Sigmaplot v12.3 (Systat Software Inc., San Jose, CA, USA).
Results
All results are reported as ranges, medians and quartiles.
Maternal and foetal fentanyl exposure. Fentanyl concentrations in maternal and foetal plasma ranged between 0.13 and 2.57 ng/ml (median, 0.52; quartiles: 0.32, 1.17) and 0.09-1.44 ng/ml (0.34; 0.21, 0.42), respectively (figs 1 and 2). In experiment 3, in which the animals received preoperative patch and intraoperative infusion, fentanyl concentrations in maternal and foetal plasma were higher than in the other two experiments.
Foetal-to-maternal concentration ratios were between 0.23 and 1.25 (0.63; 0.43, 0.75). Regardless of the fentanyl dosing protocol, a majority of F/M ratios were lower than 1. The two higher than 1 F/M ratios were observed with the lowest maternal and foetal P-fentanyl. The lowest F/M ratios were observed in experiment 3 where F/M ratios were between 0.23 and 0.56 (0.40) at steady-state at 4 hr after the first fentanyl patch application and 3 hr after a single IV bolus and continuous infusion of fentanyl ( fig. 3) .
We had eight late-paired blood samples during the second patch worn. At steady-state between 96 and 120 hr, patch worn maternal P-fentanyl was 0.16 ng/ml (0.13-0.46), foetal P-fentanyl 0.13 ng/ml (0.09-0.19) and F/M ratio 0.69 (0.43-0.85).
Foetal pH and fentanyl ion trapping.
Maternal arterial blood pH was between 7.28 and 7.60 (7.36; 7.32, 7.38), and foetal arterial blood pH was between 6.89 and 7.33 (7.16; 7.0, 7.21), respectively. Difference between foetal and maternal pH was between 0.06 and 0.43 (0.19; 0.16, 0.20).
Foetal fentanyl accumulation was not seen in this study. Pearson's product-moment correlation coefficient for foetal Table 1 . Three different fentanyl dosing regimens consisting of intravenous (IV) intramuscular (IM) and transdermal administration used in three experiments.
Fentanyl administration Intraoperative intravenous (IV) and intramuscular (IM) Transdermal
Experiment 1, n = 9 IV bolus 2 lg/kg + 1 lg/kg at every 1 hr After experiment under the tail 2 lg/kg/h IM 1 lg/kg at the end of surgery Replaced at 72 hr Experiment 2, n = 10 IV bolus 2 lg/kg + 1 lg/kg at every 30 min. Just before surgery on metatarsus 2 lg/kg/h IM 1 lg/kg at the end of surgery Replaced at 72 hr Experiment 3, n = 10 IV bolus 2 lg/kg + infusion 2.5 lg/kg/h, infusion stopped 30 min. before the end of surgery One hour before surgery on metatarsus 2 lg/kg/h Replaced at 72 hr pH, pH difference, fentanyl concentration in foetal plasma and F/M ratio indicated no significant relationship between the variables ( fig. 4) .
Discussion
In the present study, we found that foetal plasma fentanyl concentration rarely reached or exceeded that of the mother, yet foetal exposure to fentanyl was extensive after IV boluses and continuous infusion. We did not find any clear relationship between foetal acidosis and increased fentanyl concentration in foetal plasma, indicating no significant ion trapping of fentanyl. Moreover, during fentanyl, patch worn foetal exposure was relatively low. Fentanyl is a potent opioid analgesic commonly used during pregnancy and labour. As a highly lipid-soluble drug, it rapidly crosses the placenta. Fentanyl is a weak base and its accumulation to foetal tissues due to foetal acidosis is a concern. In pregnant sheep, increased foetal concentrations of lidocaine and bupivacaine have been observed at foetal blood pH of 6.9-7.2 [5, 6] . In human placental perfusion model, transplacental clearances of bupivacaine, lidocaine, chloroprocaine and sufentanil were increased when the foetal perfusate pH was lowered to 7.2 [3, 4, 13] . In contrast, in the current study, similar low foetal blood pH did not clearly affect the foetal fentanyl concentrations or concentration difference between foetus and the ewe, which indicates no ion trapping for fentanyl. In neonatal sheep, fentanyl metabolism has been reported [14] . This might cause that ion trapping of fentanyl is not observed, if occurring, because foetal liver metabolizes fentanyl right after its placental transfer and distribution to foetus. Also, F/M ratio of 0.69 during patch worn supports that foetus may have some mature metabolic capacity.
In the current study, foetal-to-maternal concentration ratio indicated no accumulation of fentanyl to the foetus despite the continuous dosing. However, in several individuals, significant foetal concentrations were obtained after IV bolus followed by a continuous infusion. Intrapartum exposure to fentanyl may have significant foetal implications. Severe respiratory depression and muscle rigidity impairing ventilation and inducing acidosis have been described [15, 16] . Therefore, accumulation of the drug to the foetus and substantial foetal exposure are unwanted when treating maternal pain with fentanyl and other opioids during pregnancy and labour. Differences in plasma protein concentrations may affect maternal and foetal fentanyl concentrations. Fentanyl protein binding has not been studied in sheep, but in vitro studies with dog plasma have shown that fentanyl is 57% and 62% bound to plasma protein in pH 7.3 and pH 7.4, respectively [7] . Based on a recent study in human beings, fentanyl binds primarily to albumin [17] . It has been reported that in nearterm sheep, maternal total protein and albumin concentrations in plasma are higher than foetal [18] , which could cause the concentration difference seen in the current study.
Analgesic fentanyl concentration for sheep is not known. However, assumed analgesic concentration range in human beings is between 0.2 and 2.0 ng/ml and is commonly extrapolated to animals [19] . This concentration was reached in all experimental protocols in both ewes and foetuses, but during recovery phase most ewes and all foetuses had lower plasma concentration at steady-state.
In conclusion, foetal-to-maternal concentration ratio for fentanyl was mainly below one after IV and transdermal administration to pregnant sheep. Foetal acidosis was not clearly correlated with ion trapping of fentanyl or drug accumulation to the foetus. Further studies are needed to assess whether the observations made in the current study have a clinical relevance in human pregnancy. . Foeto-maternal plasma pH difference and concentration ratios in the three experiments: experiment 1) IV bolus 2 lg/kg + 1 lg/kg at every 1 hr; experiment 2) 2 lg/kg/h fentanyl patch just before + IV bolus 2 lg/kg + 1 lg/kg at every 30 min.; experiment 3) 2 lg/kg/h fentanyl patch 1 hr before + IV bolus 2 lg/kg just before + 2.5 lg/kg/hr infusion.
